Impact of Rectal Spacers on Sexual Quality-of-Life After Radiotherapy in Patients With Prostate Cancer

Analysis of SpaceOAR trial and pooled data found reduced penile bulb radiation dose correlated with better preservation of sexual function over long-term follow-up, suggesting rectal spacers help maintain erectile function in some men with prostate cancer undergoing radiation therapy.

Video Player is loading.

Play Video

Play

Mute

Current Time 0:00

/

Duration 9:13

Loaded: 0%

0:00

Stream Type LIVE

Seek to live, currently behind liveLIVE

Remaining Time -9:13

 

1x

Playback Rate

Chapters

• Chapters

Descriptions

• descriptions off, selected

Captions

• captions settings, opens captions settings dialog
• captions off, selected

Audio Track

• en (Main), selected

Fullscreen

This is a modal window.

Beginning of dialog window. Escape will cancel and close the window.

Text

ColorWhiteBlackRedGreenBlueYellowMagentaCyanTransparencyOpaqueSemi-Transparent

Background

ColorBlackWhiteRedGreenBlueYellowMagentaCyanTransparencyOpaqueSemi-TransparentTransparent

Window

ColorBlackWhiteRedGreenBlueYellowMagentaCyanTransparencyTransparentSemi-TransparentOpaque

Font Size

50%75%100%125%150%175%200%300%400%

Text Edge Style

NoneRaisedDepressedUniformDropshadow

Font Family

Proportional Sans-SerifMonospace Sans-SerifProportional SerifMonospace SerifCasualScriptSmall Caps

Reset restore all settings to the default valuesDone

Close Modal Dialog

End of dialog window.

Close Modal Dialog

This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.

EP: 1.The Role of Rectal Spacers in Patients Undergoing Radiation Therapy for Prostate Cancer

EP: 2.Common Adverse Effects in Patients With Prostate Cancer Undergoing Radiation Therapy

EP: 3.Available Rectal Spacer Options for Patients With Prostate Cancer Undergoing Radiation Therapy

EP: 4.Rectal Separation for Prostate Cancer Radiation Therapy: Clinical Data on SpaceOAR and SpaceOAR Vue

EP: 5.Rectal Separation for Prostate Cancer Radiation Therapy: Clinical Data on Barrigel and BioProtect

Now Viewing

EP: 6.Impact of Rectal Spacers on Sexual Quality-of-Life After Radiotherapy in Patients With Prostate Cancer

EP: 7.Recommendations for the Use of Rectal Spacers in Clinical Practice for Patients With Prostate Cancer

EP: 8.Ongoing Studies Investigating Rectal Spacer Benefits in Patients With Prostate Cancer Undergoing Radiation Therapy

Related Videos

Advances across urology: Insights from UNC faculty

Timothy McClure, MD, on patient selection for focal therapy

Shared Decision-Making and Treatment Adherence

Related Content

Advertisement

August 19th 2025

FDA grants fast track designation to HLD-0915 in mCRPC

Hannah Clarke

August 19th 2025

Pearls & Perspectives: Helen Bernie, DO, MPH, at AUA 2025

Amy M. Pearlman, MD Helen L. Bernie, DO, MPH

August 19th 2025

Study offers insights into optimal patient selection for HIFU in prostate cancer

Hannah Clarke

August 19th 2025

Dr. Murphy on increasing diversity in cancer clinical trials

Urology Times staff

August 19th 2025

FDA greenlights phase 1 trial of NSD2 inhibitor in mCRPC

Hannah Clarke

August 19th 2025

Adding metastasis-directed therapy to ADT extends PFS in oligometastatic prostate cancer

Hannah Clarke

Related Content

Prostate CancerThe Role of Rectal Spacers in the Treatment of Prostate Cancer

Prostate Cancer

|

The Role of Rectal Spacers in the Treatment of Prostate Cancer

Advertisement

August 19th 2025

FDA grants fast track designation to HLD-0915 in mCRPC

Hannah Clarke

August 19th 2025

Pearls & Perspectives: Helen Bernie, DO, MPH, at AUA 2025

Amy M. Pearlman, MD Helen L. Bernie, DO, MPH

August 19th 2025

Study offers insights into optimal patient selection for HIFU in prostate cancer

Hannah Clarke

August 19th 2025

Dr. Murphy on increasing diversity in cancer clinical trials

Urology Times staff

August 19th 2025

FDA greenlights phase 1 trial of NSD2 inhibitor in mCRPC

Hannah Clarke

August 19th 2025

Adding metastasis-directed therapy to ADT extends PFS in oligometastatic prostate cancer

Hannah Clarke